Bamboo Fungus

Metadata

Regulatory Status

China

• Traditional use: Recorded in Chinese medicine since the 7th century CE (Tang Dynasty). The Shiliao Bencao (食疗本草) by Meng Xian described bamboo fungus as clearing the intestines, energizing the stomach, preventing aging, fighting infections, and reducing pain.
• Chinese Pharmacopoeia: Not listed as an official drug in the current Chinese Pharmacopoeia (2020 edition). Classified primarily as an edible fungus and food ingredient.
• Commercial cultivation: Widely cultivated in Fujian, Guizhou, Sichuan, and Yunnan provinces. One of China’s prized culinary mushrooms, featured prominently in Sichuan and Cantonese haute cuisine.
• Traditional indications: Laryngitis, leucorrhea, fever, oliguria, diarrhea, hypertension, cough, hyperlipidemia.

Japan

• Not listed in the Japanese Pharmacopoeia. Available as a specialty food ingredient (kinugasatake) in Japanese cuisine.

United States

• Not marketed as a dietary supplement in mainstream channels. Available as a dried culinary ingredient in Asian grocery stores. No specific GRAS determination, though consumed widely as a food.

European Union

• No novel food authorization specifically for P. indusiatus extracts or supplements. Available as a dried food ingredient in specialty markets.

Southeast Asia

• Widely consumed as a culinary ingredient across China, Vietnam, Thailand, and other Southeast Asian countries. The Miao people of southern China maintain traditional medicinal applications for injuries, cough, dysentery, enteritis, and general debility.

Conditions & Indications

Primary: Immune Modulation (Preclinical Evidence)

• Immunostimulation via polysaccharides: P. indusiatus polysaccharides, primarily beta-(1→3)-D-glucans with (1→6)-glucosyl side branches, activate macrophages, enhance phagocytosis, and stimulate cytokine production (TNF-alpha, IL-6, IL-1beta) in in vitro models. These effects are consistent with the dectin-1 and TLR-2 mediated immune activation pathway shared by other medicinal mushroom beta-glucans.
• Antitumor activity (in vivo, animal models): Regenerated triple-helical polysaccharides isolated from P. indusiatus inhibited tumor growth in mouse models. The antitumor mechanism appears to be immunostimulatory rather than directly cytotoxic, with enhanced NK cell activity and macrophage-mediated tumor suppression.

Secondary: Anti-Inflammatory and Hepatoprotective (Preclinical Evidence)

• Anti-inflammatory activity: Hot water and ethanol extracts significantly reduced NO production in LPS-stimulated cells, inhibited pro-inflammatory cytokine release, and demonstrated wound-healing properties via collagen stimulation and MMP-2 inhibition in vitro.
• Hepatoprotective and antihyperlipidemic effects: Polysaccharide fractions (both alkali- and enzyme-extracted) improved lipid profiles, strengthened antioxidant status, and attenuated hepatic cell injury in hyperlipidemic mouse models.

Emerging/Preclinical

• Anti-obesity: Dictyophora indusiata polysaccharide (DIP) supplementation reduced high-fat-diet-induced obesity in mice, ameliorating intestinal integrity and inflammatory cascades while modulating gut microbiome composition.
• Antiviral: Among 17 mushroom extracts tested, P. indusiatus demonstrated the most pronounced inhibitory effect against feline infectious peritonitis virus (FIPV) main protease (69.2% inhibition), approaching activity levels of lopinavir/ritonavir.
• Antioxidant: Multiple studies confirm strong free radical scavenging activity (DPPH, ABTS, superoxide) of both polysaccharide and phenolic fractions.
• Anti-melanogenesis: Extracts show potential cosmeceutical applications through inhibition of melanin synthesis.

Mechanism of Action

Primary Mechanisms

1. Beta-glucan immune activation: The primary polysaccharide fraction consists of beta-(1→3)-D-glucans with beta-(1→6) side branches. These polysaccharides bind pattern recognition receptors (PRRs), particularly dectin-1 and TLR-2, on macrophages and dendritic cells, triggering innate immune activation including enhanced phagocytosis, increased reactive oxygen species production, and pro-inflammatory cytokine secretion (TNF-alpha, IL-1beta, IL-6).

2. NF-kB pathway modulation: P. indusiatus extracts demonstrate dual immunomodulatory activity — polysaccharide fractions stimulate immune function via NF-kB activation in resting immune cells, while simultaneously reducing excessive inflammatory responses in activated (LPS-stimulated) cells, suggesting context-dependent immunomodulation rather than simple immunostimulation.

3. Antioxidant defense enhancement: Polysaccharide fractions upregulate endogenous antioxidant enzymes (SOD, CAT, GSH-Px) and reduce MDA (malondialdehyde) levels in animal models, protecting against oxidative damage in liver, kidney, and vascular tissues.

Secondary Mechanisms

• Lipid metabolism modulation: Polysaccharides improve lipid profiles by reducing total cholesterol, LDL cholesterol, and triglycerides while increasing HDL cholesterol, likely through modulation of hepatic lipid metabolism and bile acid signaling.
• Gut microbiome modulation: DIP supplementation in animal models increased beneficial bacteria (Lactobacillus, Bifidobacterium) and reduced pathogenic bacteria, strengthened intestinal barrier integrity, and reduced systemic endotoxin levels — contributing to anti-obesity and anti-inflammatory effects.
• Wound healing: In vitro evidence suggests acceleration of wound closure through collagen stimulation and MMP-2 (matrix metalloproteinase-2) inhibition, alongside anti-inflammatory cytokine reduction.

Clinical Evidence Summary

No human clinical trials (RCTs, open-label, or case series) have been published for Phallus indusiatus as of this writing. All pharmacological evidence derives from in vitro cell culture and animal model studies.

Key Preclinical Studies

Evidence Limitations

• No human clinical trials exist. The evidence base is entirely preclinical (in vitro and animal models).
• In vitro immunostimulatory effects may not translate directly to systemic immune enhancement in humans due to oral bioavailability barriers for high-molecular-weight polysaccharides.
• Animal study doses are not directly translatable to human dosing.
• Much of the polysaccharide research uses isolated and purified fractions that may not reflect the bioactive profile of commercially available dried mushroom products.
• Publication bias may favor positive preclinical findings.
• Extraction method (hot water, alkali, enzyme) significantly affects the polysaccharide structure and bioactivity, complicating cross-study comparison.

Safety Profile

General Assessment

Phallus indusiatus has a long history of culinary use across East and Southeast Asia, with no reported adverse effects from food consumption. It is considered a safe edible mushroom when properly prepared. Formal systematic safety and toxicology studies specific to concentrated medicinal extracts are limited.

Contraindications

• Allergy to Phallaceae fungi: Individuals with known allergy to stinkhorn fungi should avoid consumption.
• Pregnancy and lactation: While traditional food use appears safe, medicinal-dose supplementation has not been evaluated in pregnant or lactating women.

Drug Interactions

• No clinically documented drug interactions. Given the preclinical evidence for lipid-lowering and anti-inflammatory activity, theoretical interactions with statins, anticoagulants, or anti-inflammatory drugs cannot be excluded at high supplemental doses, but no evidence supports clinical significance.

Side Effects

• Common (at food consumption levels): Generally well-tolerated. No significant adverse effects reported in traditional dietary use.
• Uncommon: Possible GI discomfort if consumed in large quantities.

Toxicology

• Heavy metal accumulation: As a ground-growing mushroom, P. indusiatus can accumulate heavy metals (cadmium, lead) from contaminated soils. Sourcing from cultivated production under quality-controlled conditions is recommended.
• Preparation requirement: The fruiting body should be properly dried or cooked before consumption. The fresh spore mass (gleba) has an unpleasant odor and is typically removed before culinary or medicinal use.
• No acute or subchronic toxicity studies of concentrated polysaccharide extracts have been published.

Clinical Dosage

Traditional Culinary-Medicinal Use (Dried Fruiting Body)

• Food preparation: 5—15 g of dried fruiting body rehydrated and added to soups, stir-fries, or decoctions
• Traditional decoction: No standardized medicinal dose established in pharmacopoeia; traditional use is primarily as a food-medicine

Polysaccharide Extracts (Research Context Only)

• Animal study doses: Typically 100—400 mg/kg body weight of polysaccharide extract in mouse models
• Human-equivalent dose: No established human dosage from clinical trials
• Note: All dosage information is extrapolated from traditional food use and preclinical research; no standardized medicinal dosing guidelines exist

Form Selection Guidance

P. indusiatus is predominantly consumed as a whole food (dried fruiting body in soups and dishes) rather than as a concentrated supplement. Hot-water extraction captures water-soluble polysaccharides and represents the preparation method most consistent with traditional use. Dual extraction (hot water + ethanol) captures additional terpenoid and phenolic fractions. No standardized extract products are widely available commercially.

Sources

• Hua Y, Gao Q, Wen L, Yang B, Tang J, You L, Zhao M. Structural characterisation of acid- and alkali-soluble polysaccharides in the fruiting body of Dictyophora indusiata and their immunomodulatory activities. Food Chem. 2012;132(2):739-743
• Wang Y, Ji X, Yan M, et al. Antihyperlipidemic and hepatoprotective properties of alkali- and enzyme-extractable polysaccharides by Dictyophora indusiata. Sci Rep. 2019;9:14266
• Kanwal S, Aliya S, Xin Y. Anti-obesity effect of Dictyophora indusiata mushroom polysaccharide (DIP) in high fat diet-induced obesity via regulating inflammatory cascades and intestinal microbiome. Front Endocrinol. 2020;11:558874
• Liao W, Luo Z, Liu D, Ning Z, Yang J, Ren J. Structure characterization of a novel polysaccharide from Dictyophora indusiata and its macrophage activating function. J Agric Food Chem. 2015;63(2):535-544
• Deng C, Shang J, Fu H, et al. Mechanism of the immunostimulatory activity by a polysaccharide from Dictyophora indusiata. Int J Biol Macromol. 2016;91:440-449
• Ker YB, Chen KC, Chyau CC, et al. Antioxidant capability of polysaccharides fractionated from submerge-cultured Agaricus blazei mycelia. J Agric Food Chem. 2005;53(18):7052-7058
• Shiv P, Prayagraj UP. High efficiency in vitro wound healing of Dictyophora indusiata extracts via anti-inflammatory and collagen stimulating (MMP-2 inhibition) mechanisms. J Ethnopharmacol. 2022;282:114642
• Chaiyasut C, Woraharn S, Sivamaruthi BS, et al. Evaluation of the dual antiviral and immunomodulatory effects of Phallus indusiatus in a feline infectious peritonitis model using PBMCs. Vet Sci. 2025;12(9):847
• Oyetayo VO, Dong CH, Yao YJ. Antioxidant and antimicrobial properties of aqueous extract from Dictyophora indusiata. Open Mycol J. 2009;3:20-26
• Lee IK, Yun BS, Han G, et al. Dictyoquinazols A, B, and C, new neuroprotective compounds from the mushroom Dictyophora indusiata. J Nat Prod. 2002;65(12):1769-1772
• Peng Y, Zhang L, Zeng F, Kennedy JF. Structure and antitumor activities of the water-soluble polysaccharides from Ganoderma tsugae mycelium. Carbohydr Polym. 2005;59(3):385-392
• Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Vol 1. 2020 Edition

Connections

• Polysaccharide-rich medicinal mushrooms: The beta-glucan immunomodulatory activity of P. indusiatus parallels that of Turkey Tail (Trametes versicolor), Maitake (Grifola frondosa), and Shiitake (Lentinula edodes). All share dectin-1/TLR-2 mediated innate immune activation, though the specific polysaccharide structures and branching patterns differ.
• Culinary-medicinal fungi: Like Tremella (Tremella fuciformis), P. indusiatus occupies a dual role as both prized culinary ingredient and traditional medicine in Chinese culture. Both are frequently used in Chinese soups and valued for their polysaccharide content, though tremella has more developed clinical evidence for skin health applications.
• Hepatoprotective mushrooms: The lipid-lowering and hepatoprotective properties of P. indusiatus polysaccharides complement similar findings for Reishi (Ganoderma lucidum) triterpenoids and Maitake beta-glucans, though through potentially distinct mechanistic pathways.
• Gut microbiome modulation: The prebiotic-like effects of DIP on gut microbiome composition parallel emerging research on polysaccharides from Shiitake and other medicinal mushrooms, suggesting a class-wide effect of fungal beta-glucans on intestinal ecology.